{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:34Z","timestamp":1787026294662,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study conducted a meta-analysis comparing vancomycin and linezolid for treating central nervous system (CNS) infections, addressing the lack of comprehensive evaluations in existing research on antibiotic therapy for CNS infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched databases, including the PubMed, Embase, Web of Science, Cochrane Library and Chinese databases, up to April 22, 2025. All eligible randomized controlled trials and cohort studies of vancomycin or linezolid were included. The clinical success rate was the primary outcome of interest. The secondary outcomes of interest were cerebrospinal fluid (CSF) parameters, systemic inflammatory markers and the occurrence of adverse drug reactions (ADRs). Two reviewers independently extracted the data and assessed the study quality (NOS\/ROB 2.0). The meta-analysis employed random\/fixed-effects models to calculate pooled dichotomous outcomes (ORs) and continuous outcomes (SMDs) with 95% CIs via RevMan 5.4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This meta-analysis included 17 studies (6 head-to-head). Clinical cure rates were not significantly different between vancomycin (84.7%, 222\/262) and linezolid (79.7%, 200\/251), with a pooled OR of 1.29 (95% CI: 0.55\u20132.99; p =0.56), while substantial heterogeneity existed (I\n                      <jats:sup>2<\/jats:sup>\n                      = 58%). The secondary outcomes showed no differences but suffered extreme heterogeneity (I\u00b2 &amp;gt;90%). Safety analysis revealed a significantly greater ADR with vancomycin (21.0% vs. 15.1%; OR 1.63, 95% CI: 1.01\u20132.65; p = 0.05) with low heterogeneity (I\u00b2 = 15%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Vancomycin and linezolid have similar effectiveness in CNS infection from current available evidences, but vancomycin is associated with a greater risk of ADR. Treatment selection should be based on patients\u2019 individual characteristics, such as risk of thrombocytopenia, renal function, and availability of therapeutic drug monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2025.1668983","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T05:31:08Z","timestamp":1758173468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative effectiveness and safety of vancomycin versus linezolid for the treatment of central nervous system infections: a meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Liujun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zecheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cmi.2023.08.016","article-title":"European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults","volume":"30","author":"Bodilsen","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaa114","article-title":"Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK","volume":"3","author":"Brown","year":"2021","journal-title":"JAC Antimicrob. Resist."},{"key":"B3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jmii.2020.08.004","article-title":"Linezolid as salvage therapy for central nervous system infections due to methicillin-resistant Staphylococcus aureus at two medical centers in Taiwan","volume":"53","author":"Chen","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B4","unstructured":"Cheng\n              Y.\n            \n          \n          Shijiazhuang, China\n          Hebei Medical University\n          Analysis of the effect of intravenous drip combined with intrathecal injection of norvancomycin hydrochloride in patients with intracranial infection [master\u2019s thesis]\n          \n          2018"},{"key":"B5","first-page":"329","article-title":"Clinical study of intracranial infections in patients undergoing cerebrospinal fluid shunt through craniotomy","volume":"26","author":"Dai","year":"2016","journal-title":"Chin. J. Nosocomiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.11816\/cn.ni.2015-150847","article-title":"Therapeutic efficacy of cerebrospinal fluid replacement combined with different intrathecal injections in patients with intracranial infection after craniotomy","volume":"25","author":"Dan","year":"2015","journal-title":"Chin. J. Nosocomiol."},{"key":"B7","unstructured":"Huang\n              C. W.\n            \n          \n          Jilin, China\n          Jilin Medical University\n          Clinical analysis of curing intracranial infetion by injectingvancomycin into cerebral ventricle and canalis spinalis [master\u2019s thesis]\n          \n          2009"},{"key":"B8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12879-025-10834-5","article-title":"Vancomycin versus linezolid for treatment of staphylococcal-associated central nervous system infections","volume":"25","author":"Lahouati","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1056148","article-title":"Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.11816\/cn.ni.2016-152573","article-title":"Clinical effect of intrathecal injection of antibiotics on treatment of patients with intracranial infections after craniotomy","volume":"26","author":"Liu","year":"2016","journal-title":"Chin. J. Nosocomiol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle\u2013Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood\u2013brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1345\/aph.1H307","article-title":"Linezolid for the treatment of patients with central nervous system infection","volume":"41","author":"Ntziora","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/23744235.2020.1789212","article-title":"Linezolid for therapy of Staphylococcus aureus meningitis: a cohort study of 26 patients","volume":"52","author":"Pintado","year":"2020","journal-title":"Infect. Dis. (Lond)"},{"key":"B15","first-page":"222","article-title":"Clinical effects of meropenem and linezolid on treatment of postoperative intracranial infections","volume":"28","author":"Qu","year":"2018","journal-title":"Chin. J. Nosocomiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3760\/cma.j.issn.1674-2397.2019.02.007","article-title":"Clinical efficacy of linezolid and vancomycin in treatment of intracranial staphylococcal infection after neurosurgery","volume":"12","author":"Qin","year":"2019","journal-title":"Chin. J. Nosocomiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11020173","article-title":"Efficacy of vancomycin and meropenem in central nervous system infections in children and adults: current update","volume":"11","author":"Schneider","year":"2022","journal-title":"Antibiot. (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomized trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3969\/j.issn.1001-8131.2024.01.024","article-title":"Clinical efficiency of vancomycin combined withdexamethasone intrathecal injection for the treatment ofintracranial pyogenic infection","volume":"44","author":"Sun","year":"2024","journal-title":"Harbin Med. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1179\/joc.2010.22.1.17","article-title":"Linezolid penetration into cerebrospinal fluid and brain tissue","volume":"22","author":"Tsona","year":"2010","journal-title":"J. Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases society of America\u2019s Clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: diagnosis and treatment of acute bacterial meningitis","author":"van de Beek","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMra0804573","article-title":"Nosocomial bacterial meningitis","volume":"362","author":"van de Beek","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B25","first-page":"50","article-title":"Clinical efficiency of vancomycin combined withdexamethasone intrathecal injection for the treatment ofintracranial pyogenic infection","volume":"31","author":"Wang","year":"2011","journal-title":"Chin. J. Hosp. Pharmacy"},{"key":"B26","first-page":"15485","article-title":"Comparison of the curative efficacy of intrathecal and intravenous injection of ceftriaxone and vancomycin in the treatment of intracranial infection during the perioperative period","volume":"10","author":"Wang","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B27","first-page":"5156","article-title":"Effect of neuroendoscopy combined with different antibiotics on treatment of intracranial infections after ventricle - peritoneal shunt","volume":"26","author":"Xiao","year":"2016","journal-title":"Chin. J. Nosocomiol."},{"key":"B28","first-page":"361","article-title":"Effect of intrathecal injection of vancomycin on intracranialinfections after craniotomy","volume":"9","author":"Xu","year":"2010","journal-title":"Chin. J. Infect. Control."},{"key":"B29","first-page":"1368","article-title":"Comparative analysis of clinical efficacy, safety and economy of vancomycin and linezolid in the treatment of intracranial infection after neurosurgery operation","volume":"29","author":"Yang","year":"2018","journal-title":"China Pharmacy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.13286\/j.1001-5213.2024.07.12","article-title":"Comparison of efficacy and safety of vancomycin and linezolid for central nervous system infections","volume":"44","author":"Yang","year":"2024","journal-title":"Chin. J. Hosp. Pharmacy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/IDR.S219989","article-title":"Serum concentration of vancomycin is a diagnostic predictor of nephrotoxic acute kidney injury in septic patients in clinical and surgical wards","volume":"13","author":"Zamoner","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"B32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/1440-1681.13066","article-title":"Vancomycin dosing, monitoring and toxicity: Critical review of the clinical practice","volume":"46","author":"Zamoner","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B33","first-page":"2760","article-title":"Influence of lumbar cistern drainage combined withintrathecal injection on serum NSE, hs-CRP and PCT ofhypertensive cerebral hemorrhage patients withpostoperative intracranial infections","volume":"27","author":"Zheng","year":"2017","journal-title":"Chin. J. Nosocomiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1668983\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T05:31:15Z","timestamp":1758173475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1668983\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":33,"alternative-id":["10.3389\/fcimb.2025.1668983"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1668983","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"1668983"}}